Congo vs Honduras: Antiretroviral therapy coverage for PMTCT
Congo
42.0%
in 2024
Honduras
42.0%
in 2024
Congo rank
70th
Honduras rank
70th
Antiretroviral therapy coverage for PMTCT over time
- Congo
- Honduras
How they compare
Congo currently reports 42.0% against 42.0% in Honduras, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Honduras ahead.
Congo ranks 70th and Honduras ranks 70th of 84 countries.
Honduras has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Congo | Honduras | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.2% | 13.6% | 8.4% | Honduras |
| 2010s | 15.4% | 45.1% | 29.7% | Honduras |
| 2020s | 27.0% | 43.6% | 16.6% | Honduras |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Congo or Honduras?
- Congo, at 42.0% against 42.0% in Honduras as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Congo and Honduras?
- 0.0%, with Congo ahead.
- How many years of comparable data are there for Congo and Honduras?
- 25 years are reported by both, from 2000 to 2024.
- How do Congo and Honduras rank globally for antiretroviral therapy coverage for pmtct?
- Congo ranks 70th and Honduras ranks 70th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).